Navigation Links
InteKrin Therapeutics to Present at the 2009 American Diabetes Association Annual Meeting
Date:5/28/2009

LOS ALTOS, Calif., May 28 /PRNewswire/ -- InteKrin Therapeutics, Inc. announced today it will present Phase 2a clinical data for INT131, a Selective PPAR Modulator (SPPARM), at the American Diabetes Association annual meeting in New Orleans Saturday, June 6, 2009 during the "Novel Diabetes Therapies in Development in Humans" session at 4:00 pm CDT.

Dr. Alex DePaoli, Chief Medical Officer of InteKrin Therapeutics, will provide a summary of the latest clinical data supporting the design of INT131 to safely and effectively address insulin resistance in a presentation entitled "INT131: Significantly Lowers Glucose Without Typical Thiazolidinedione (TZD) Side Effects in Patients with Type 2 Diabetes."

About INT131

INT131 is a next-generation insulin sensitizer currently in Phase 2b testing that addresses insulin resistance, a key etiological feature in the onset and subsequent progression of type 2 diabetes. Purposefully designed as a SPPARM, INT131 selectively modulates PPAR-gamma, thereby allowing the retention of the clinically proven anti-diabetic efficacy of PPAR gamma activation, while mitigating or eliminating the well recognized side effects of TZD full PPAR gamma agonists rosiglitazone and pioglitazone (Avandia(R) and Actos(R) respectively).

About InteKrin (www.InteKrin.com)

InteKrin Therapeutics is a privately-held clinical-stage drug development company focused on diabetes, obesity and metabolic disease. InteKrin's business strategy is to build a robust portfolio of high value products by in-licensing clinical-stage therapeutic candidates that address significant unmet medical needs and rapidly move them through critical development stages. InteKrin's team of world-class scientific and medical experts includes veterans from several successful BioPharma organizations, internationally recognized experts in nuclear receptors and me
'/>"/>

SOURCE InteKrin Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. InteKrin Therapeutics Announces Enrollment Completion of 360 Patient, 24 week Phase 2b Study
2. InteKrin Therapeutics Announces Initiation of Phase 2b Study in Type 2 Diabetes with INT131
3. Fate Therapeutics Announces First Patient Treated in Phase 1b Clinical Trial of FT1050 for Hematopoietic Stem Cell Support
4. Ascenta Therapeutics Announces Multiple Presentations on AT-101 at 2009 ASCO Annual Meeting
5. Oxford BioTherapeutics and GlaxoSmithKline Form Strategic Alliance to Develop Novel Cancer Therapeutic Antibodies
6. FDA Accepts Arno Therapeutics IND for AR-12 a PDK1 Inhibitor That Blocks the PI3K/Akt Pathway
7. Logical Therapeutics Appoints Peter A. Lankau as CEO and Director
8. Arcion Therapeutics Topical Pain Candidate, ARC-4558, Significantly Reduces Pain Caused by Diabetic Neuropathy
9. Trius Therapeutics Announces Presentations Featuring Torezolid Antibiotic at the 19th European Congress of Clinical Microbiology and Infectious Diseases
10. Hyperion Therapeutics Receives Orphan Drug Designation for HPN-100 for the Treatment of Urea Cycle Disorders
11. Sirion Therapeutics Announces Clinical Data Presentations at the 2009 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2015)... PUNE, India , August 27, 2015 ... market research reports reviewing the genotyping technology, ... as well as single nucleotide polymorphism (SNP) ... ReportsnReports.com. Complete report on genotyping ... spread across 200 pages, profiling 10 major ...
(Date:8/26/2015)... NEW YORK , Aug. 26, 2015 ... estimated to witness a CAGR of 7.8% during the ... North American ophthalmology cataract surgery devices market in 2014 ... North American ophthalmology cataract surgery devices market is expected ... owing to the increasing strategic expansion of the companies ...
(Date:8/26/2015)... 2015 Edwards Lifesciences Corporation (NYSE: EW ... valves and hemodynamic monitoring, today announced that it has ... privately held company and developer of a transcatheter mitral ... had signed an agreement to acquire CardiAQ. ... $350 million cash for CardiAQ at closing, with an ...
Breaking Medicine Technology:Genotyping Market Forecast to Grow at 22.3% CAGR to 2020 2Genotyping Market Forecast to Grow at 22.3% CAGR to 2020 3Genotyping Market Forecast to Grow at 22.3% CAGR to 2020 4Genotyping Market Forecast to Grow at 22.3% CAGR to 2020 5North America Ophthalmology Cataract Surgery Devices Market by Sub-Market, by End-User - Analysis and Forecast to 2019 2North America Ophthalmology Cataract Surgery Devices Market by Sub-Market, by End-User - Analysis and Forecast to 2019 3Edwards Lifesciences Corporation Completes Acquisition Of CardiAQ 2
(Date:8/27/2015)... CA (PRWEB) , ... August 27, 2015 , ... ... plans to enter the exploding legal marijuana industry with the launch of its ... consumers of legal marijuana to order products from their smart phones and tablets. ...
(Date:8/27/2015)... ... August 27, 2015 , ... About 10 percent of ... the Gulf Coast, killing more than 1,800 people, displacing hundreds of thousands and ... State University study. , While most people don’t develop persistent depression after a ...
(Date:8/27/2015)... ... ... The Naderi Center is proud to announce that its own Dr. ... submental fat. The first and only Food and Drug Administration (FDA) approved treatment ... the only Board Certified surgeon in the D.C., Maryland, Virginia area to offer this ...
(Date:8/27/2015)... Yardley, Penn. (PRWEB) , ... August 27, 2015 ... ... engagement solutions, confirmed today that its Krames Patient Education content is ICD-10 ready ... and is ready for the new ICD-10 code sets, which are more targeted ...
(Date:8/27/2015)... ... August 27, 2015 , ... Zensah®, ... Glushko, professional Tennis player for Israel in the Women’s Tennis Association (WTA). Glushko ... her training and recovery. , With a focus on technology and comfort, Zensah® ...
Breaking Medicine News(10 mins):Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 2Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 3Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 4Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 5Health News:About 10 Percent of Mothers Experienced Depression Two Years After Hurricane Katrina, New Study Shows 2Health News:Noninvasive Double Chin Elimination Now Available in Herndon and Chevy Chase 2Health News:Noninvasive Double Chin Elimination Now Available in Herndon and Chevy Chase 3Health News:StayWell announces all health content is ICD-10 ready 2Health News:StayWell announces all health content is ICD-10 ready 3Health News:Zensah® Compression Announces Partnership with WTA Tennis Professional Athlete, Julia Glushko 2Health News:Zensah® Compression Announces Partnership with WTA Tennis Professional Athlete, Julia Glushko 3
... cell startlingly similar to its human counterpart will likely ... organ tissue in people, two studies reported Wednesday. ... the inner-most layer of week-old rodent embryos, will provide ... diseases and injuries, the researchers said. ,"They ...
... Czech authorities said Wednesday the H5N1 virus, which is potentially lethal ... its recent discovery among wild birds in Germany. ... farm near the village of Norin, just four kilometers (2.5 miles) ... after the virus was detected there. ,The farm in ...
... the world, but the situation remains critical in Egypt and ... a major human threat remains high, the UN health ... countries in Asia, Eastern Europe and the Middle East where ... it was rapidly detected and eliminated or controlled," said Joseph ...
... Saing Ratha lies semi-conscious, her thin body shaking with fever as ... ice under her arms. ,Her 10-year-old bother Saing ... in this spartan rural clinic. ,Both have been struck ... in the first six months of this year as during the ...
... Ever dreamed of being drawn close to a smiling Marilyn ... ,A Japanese firm on Wednesday unveiled a ... of three-dimensional images using a sensor-loaded glove. ,The ... of a screen and has a glove that allows users ...
... authorities and United Nations agencies said Thursday they will immunise ... in history. ,The virulent disease is one ... the lives of 58 children a day, but vaccination coverage ... the largest immunization campaign in the world. I think it ...
Cached Medicine News:Health News:'Missing Link' Stem Cells may Shorten Path to Therapies 2Health News:'Missing Link' Stem Cells may Shorten Path to Therapies 3Health News:Potentially Lethal H5N1 Bird Flu Resurfaces in Europe 2Health News:Bird Flu Risk Still Running High in Egypt, Indonesia, WHO Says 2Health News:Dengue Deaths Sweeping Cambodia Highlight Healthcare Failures 2Health News:Dengue Deaths Sweeping Cambodia Highlight Healthcare Failures 3Health News:Pakistan to Launch World's Biggest Anti-measles Drive 2
Enhances the eye color of light-eyed patients....
Expressions Accents contact lenses let you enhance your eyes natural color while enjoying incredible comfort and outstanding vision quality....
Modern, innovative and quick Intense Pulsed Light system. The Flash 1 is light and very compact, thus easily portable. Available in two different colors....
... Vasculight SR improves the appearance of photo-aged ... benign brown pigments, telangiectasias, and broken capillaries. ... pulsed light (IPLTM) treats pigmentary sun damage ... combined approach of IPL and the Nd:YAG ...
Medicine Products: